Stellar Biotechnologies (OTCQB: SBOTF) (TSX-V: KLH), a
leading manufacturer of Keyhole Limpet Hemocyanin (“KLH”) protein for
generation of antibody and cell-mediated immune responses against disease
indications, has received approval for its common shares to begin trading on
The NASDAQ Capital Market as of November 5, 2015, under the symbol “SBOT.”
“This is a significant milestone for Stellar and an
important step in our corporate growth,” Frank Oakes, president, CEO and
chairman, of Stellar stated in the news release. “We anticipate that the
listing of our shares on NASDAQ will raise our visibility within the investment
community and with institutional investors, and will offer our shareholders an
opportunity for increased liquidity. This approval comes at an important time
for Stellar, as evidenced by our recently announced plan to expand
manufacturing capacity to meet growing demand for KLH protein in immunotherapy.
We look forward to sharing our future achievements with investors, customers,
and collaborators.”
In recognition of the achievement, Nasdaq has invited
Stellar to ring the Nasdaq Closing Bell tomorrow afternoon, the first day of
the company’s trade on the exchange. Oakes and members of Stellar’s management
team will participate in the Nasdaq closing ceremony on Thursday, November 5,
2015, at 4 p.m. ET at the Nasdaq MarketSite in New York City. The event will be
broadcast live via Nasdaq’s livestream portal at
http://livestream.com/nasdaq/live.
For more information visit www.stellarbiotechnologies.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
